11/19
09:14 am
qlgn
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares [Yahoo! Finance]
High
Report
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares [Yahoo! Finance]
11/19
09:00 am
qlgn
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Medium
Report
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
9/26
05:28 pm
qlgn
Qualigen Therapeutics announces management changes Sep. 26, 2024 5:28 PM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]
Neutral
Report
Qualigen Therapeutics announces management changes Sep. 26, 2024 5:28 PM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]
9/26
05:18 pm
qlgn
Qualigen Therapeutics, Inc. Announces management changes. [Yahoo! Finance]
Neutral
Report
Qualigen Therapeutics, Inc. Announces management changes. [Yahoo! Finance]
9/26
05:10 pm
qlgn
Qualigen Therapeutics, Inc. Announces management changes.
Neutral
Report
Qualigen Therapeutics, Inc. Announces management changes.
9/20
09:00 am
qlgn
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
Medium
Report
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
9/6
05:00 pm
qlgn
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Low
Report
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
9/6
04:45 pm
qlgn
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering [Yahoo! Finance]
Low
Report
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering [Yahoo! Finance]
9/6
04:30 pm
qlgn
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
Medium
Report
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
9/5
09:00 am
qlgn
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering
High
Report
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering